Long COVID may involve autoantibodies that target the nervous system

ByBrian “Weence” Bateman

A new Cell study suggests that, for some people with Long COVID, the immune system may produce autoantibodies that recognize nervous-system targets—linked to specific neurological symptom patterns. But there’s still no routine blood test or proven, antibody-targeted treatment for everyday care.

Long COVID can affect the brain, nerves, and thinking—but it isn’t one single illness. A new study published in Cell (highlighted by the U.S. National Institutes of Health, NIH) adds evidence that, in at least some people, the immune system may play a role in neurological symptoms through autoantibodies—antibodies that mistakenly react with the body’s own tissues.

What the newest Cell study found

NIH summarizes that researchers studied blood antibodies from 147 people. Compared with healthy people, antibodies from people with Long COVID—and from some who recovered from COVID-19—reacted more often to human nervous-system tissue.

The NIH summary also reports that the antibodies’ targets (where they bind) tracked with clusters of neurological symptoms. For example, antibodies targeting a brain area called the locus coeruleus were linked with certain symptoms (including reported loss of taste and smell) and other complaints such as nausea and joint pain.

To explore whether antibodies could contribute to symptoms, the researchers transferred antibodies into mice. NIH reports that mice receiving antibodies tied to chronic pain became more sensitive to pain, while antibodies associated with dizziness were linked with balance instability. Mice also differed from controls on a moving treadmill task.

Why this matters—and what it doesn’t mean yet

The practical takeaway is subgroup thinking: Long COVID may involve different biological processes in different people. This study is trying to connect one possible process—autoantibodies recognizing nervous-system targets—to specific neurological symptom patterns.

But major uncertainties remain:

  • Not a ready diagnosis. CDC notes that no laboratory test can definitively diagnose or rule out Long COVID today or distinguish it from conditions with different causes.
  • Not proven for every person. NIH emphasizes that more research is needed to connect specific autoantibodies to particular Long COVID symptoms, and that autoantibodies may not be the only driver.
  • Animal results aren’t personal clinical proof. Mouse experiments are biologically suggestive, but they don’t automatically confirm the same cause-and-effect mechanism for an individual patient’s symptoms.

How CDC guidance fits into this news (U.S.)

CDC’s clinical guidance focuses on patient-centered evaluation—using history and physical exam—and shared decision-making. CDC also notes that a positive viral or antibody test is not required to establish a Long COVID diagnosis; it can help assess whether there was current or prior infection.

CDC also stresses that Long COVID symptoms can be hard to explain, can overlap with other chronic conditions, and may require comprehensive care.

Who may want to pay attention to the neurological angle

This line of research is most relevant to people whose Long COVID experience includes neurological symptoms such as difficulty thinking or concentrating (brain fog), headaches, sleep problems, dizziness/lightheadedness, or related issues.

If your symptoms are new, worsening, or affecting daily function, a reasonable next step is to seek medical evaluation—not to self-diagnose based on emerging lab-mechanism ideas.

What you can do now in a clinic conversation

  • Document symptom patterns. Track what symptoms are most impairing, when they started, and what makes them better or worse.
  • Ask clinicians to evaluate other possible causes. CDC’s guidance reflects that Long COVID symptoms can overlap with other conditions that need different management.
  • Use the “function and quality of life” frame. CDC recommends symptom-focused care and goal-setting to improve day-to-day functioning.
  • Be cautious with emerging tests. Even if an autoantibody mechanism is real for a subgroup, CDC guidance indicates there’s not a definitive lab test for routine diagnosis today.

When neurological symptoms are an emergency

Long COVID can include neurological symptoms—but some symptoms need urgent evaluation. If someone has emergency warning signs, call 911 or go to the nearest emergency department.

CDC’s COVID-19 emergency warning signs include:

  • Trouble breathing
  • Persistent pain or pressure in the chest
  • New confusion
  • Inability to wake or stay awake
  • Pale, gray, or blue lips, nail beds, or skin (depending on skin tone)

If symptoms are concerning but not emergent, contact a clinician promptly for guidance.

Key sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.

Related

Brian “Weence” Bateman is a health and medical writer who covers public health updates, healthcare policy, and medical developments affecting communities across the United States. He works closely with dentists and healthcare providers and focuses on making complex medical information clear, accurate, and useful for everyday readers.